Publication Name	World Journal of Clinical Oncology
Manuscript ID	62414
Country	United States

Received	2021-01-07 22:52
Peer-Review Started	2021-01-14 16:15
To Make the First Decision
Return for Revision	2021-03-01 02:57
Revised	2021-03-04 03:57
Second Decision	2021-05-17 08:34
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-05-17 12:03
Articles in Press	2021-05-17 12:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-05-18 08:45
Publish the Manuscript Online	2021-05-22 10:39

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Emergency Medicine
Manuscript Type	Minireviews
Article Title	COVID-19: Where is the treatment?
Manuscript Source	Invited Manuscript
All Author List	Bonala Sabeerabi, Sarojamma Vemula, Ramakrishna Vadde and Ganji Purnachandra Nagaraju
Funding Agency and Grant Number
Corresponding Author	Ganji Purnachandra Nagaraju, DSc, PhD, Instructor, Department of Hematology and Medical Oncology, Emory University, 1365 Clifton Rd Winship C # 3025, Atlanta, GA 30322, United States. pganji@emory.edu
Key Words	COVID-19; Meta-analysis; Therapeutics; Anti-viral drugs; Immune therapy; Corticosteroids
Core Tip	The outcomes from these studies, supporting the use of anti-corona therapies, remain mostly inconclusive and uninspiring, so far, because of the lack of evidence, methodological flaws, missing data entries, risk of bias, publication bias, heterogeneity of outcomes and the number of subjects included in the respective studies. High-quality data from more stringent studies involving large samples, particularly randomized clinical studies, and caution on when to employ the treatments are needed.
Publish Date	2021-05-22 10:39
Citation	Sabeerabi B, Vemula S, Vadde R, Nagaraju GP. COVID-19: Where is the treatment? World J Clin Oncol 2021; 12(5): 309-322
URL	https://www.wjgnet.com/2218-4333/full/v12/i5/309.htm
DOI	https://dx.doi.org/10.5306/wjco.v12.i5.309

Full Article (PDF)	WJCO-12-309.pdf
Full Article (Word)	WJCO-12-309.docx
Manuscript File	62414_Auto_Edited-JPY.docx
Answering Reviewers	62414-Answering reviewers.pdf
Audio Core Tip	62414-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	62414-Conflict-of-interest statement.pdf
Copyright License Agreement	62414-Copyright license agreement.pdf
Peer-review Report	62414-Peer-review(s).pdf
Scientific Misconduct Check	62414-Bing-Wang JL-1.jpg
Scientific Misconduct Check	62414-Bing-Fan JR-2.png
Scientific Misconduct Check	62414-Scientific misconduct check.pdf
Scientific Editor Work List	62414-Scientific editor work list.pdf
CrossCheck Report	62414-CrossCheck report.pdf
CrossCheck Report	62414-CrossCheck.png